Please note: This trial has finished recruiting and is not accepting new participants.
Research Center: CTI Clinical Research Center
Location: 1775 Lexington Ave, Suite 200, Cincinnati, OH
Lead Doctor: Dr Stephen J. Poland
Ethics Committee: This study has been reviewed and approved by the Schulman Institutional Review Board
Researcher interview:
Background
Over 30 million Americans suffer from migraines. Migraine is a debilitating disorder which includes throbbing headaches sometimes accompanied by nausea, vomiting and sensitivity to light and sound.
This research study is testing a new investigational drug for the treatment of migraine symptoms.
This study seeks men and women who currently suffer from migraines. Participants are required to attend 3 study visits at the research site over 3 months and may be compensated up to $455 for participating in this study.
Benefits of Participation
- You may be compensated up to $455 for participating in this study.
- You may be helping to advance medical research.
Your Rights
- If you decide to participate in the study and later feel that you no longer wish to be part of it, you may withdraw at any time.
- Your records relating to this study and any other information received will be kept strictly confidential, except as required by the law.
- Qualified health professionals will monitor your health as it relates to the study.
Who Can Participate?
- Men and women aged 18+ who suffer from migraines for more than 1 year
- Experience about 2 – 8 migraines per month
- Otherwise healthy
- Able to attend 3 study visits at the research site over approximately 3 months